Injection Sclerotherapy

ABSTRACT

Injection sclerotherapy is an important primary and adjunctive therapy in the spectrum of care for superficial venous insufficiency. This article briefly reviews the history of the procedure, agents used, technique, and outcomes. The place of injection sclerotherapy in the treatment of superficial venous disease is discussed.

KEYWORDS

Injection sclerotherapy - telangiectasia - varicose veins

REFERENCES

• 1 Goldman M P, Bergan J J. Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins. 3rd ed. St. Louis; Mosby 2001: 1-6
• 2 Linser P. Über die Konservative Behandlung der Varicen.  Med Klin. 1916;  12 897-902
• 3 Sicard J A, Roger H. Traitement des varices par injections intraveineusses locales de carbonate de soude.  Marseille Med. 1921;  4 97
• 4 McCausland S. The modern treatment of varicose veins.  Med Press Circ. 1939;  201 404-410
• 5 Foley W T. The eradication of venous blemishes.  Cutis. 1975;  15 665-668
• 6 Alderman D B. Therapy for essential cutaneous telangiectasias.  Postgrad Med. 1977;  61 91-95
• 7 Duffy D M. Small vessel sclerotherapy: an overview.  Adv Dermatol. 1988;  3 221-242
• 8 Green A R, Morgan B DG. Sclerotherapy for venous flare.  Br J Plast Surg. 1985;  38 241-242
• 9 Tessari L. Metodique extemporaine de la préparation de la “scléromousse” en syringe de plastique monousage. Presented at the French Society of Phlebology, December 11 1999 Paris, France;
• 10 Gandini R, Reale C A, Spinelli A, Konda D, Pendenza G, Simonetti G. Transcatheter embolization of male varicocele with fibro-vein mousse infusion: experience with 230 patients. Presented at Annual Meeting and Postgraduate Course of the Cardiovascular and Interventional Radiology Society of Europe (CIRSE), September 25-29 2004 Barcelona, Spain;
• 11 Gandini R, Fabiano S, Spinelli A et al.. Ovarian varices treatment by transcatheter embolization. Presented at Annual Meeting and Postgraduate Course of the Cardiovascular and Interventional Radiology Society of Europe (CIRSE), October 5-9 2002 Lucerne, Switzerland;
• 12 Goldman M P, Kaplan R P, Duffy D M. Postsclerotherapy hyperpigmentation: a histologic evaluation.  J Dermatol Surg Oncol. 1987;  13 547-550
• 13 Davis L T, Duffy D M. Determination of incidence and risk factors for postsclerotherapy telangiectatic matting of the lower extremity: a retrospective analysis.  J Dermatol Surg Oncol. 1990;  16 327-330
• 14 Bergan J J, Weiss R A, Goldman M P. Extensive tissue necrosis following high-concentration sclerotherapy for varicose veins.  Dermatol Surg. 2000;  26 535-542
• 15 Cabrera J, Cabrera J, Garcia-Olmedo M A. Sclerosants in microfoam: a new approach in angiology.  Int Angiol. 2001;  20 322-329
• 16 Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.  Dermatol Surg. 2002;  28 11-15

SUGGESTED READINGS

• 17 American College of Phlebology Web site .http://Available at: www.phlebology.org
• 18 Goldman M P, Bergan J J. Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins. 3rd ed. St. Louis; Mosby 2001
• 19 Weiss R A, Feied C, Weiss M A. Vein Diagnosis and Treatment: A Comprehensive Approach. New York; McGraw-Hill 2001